New trials, publications, preprints and grants on this target, month by month.
Publication
Genomic ascertainment refines the population prevalence and phenotype associations of germline TERT variants.
5 Nov 2026· PLoS genetics· PUBMED
Publication
Histology-dependent coupling of TERT to the proliferation programme statistically accounts for much of the between-cohort heterogeneity in DNMT3B-TERT co-expression in oesophageal carcinoma: a 27-cohort meta-analysis and pan-cancer re-analysis.
31 Oct 2026· Functional & integrative genomics· PUBMED
Publication
Restoration of radioiodine avidity after lenvatinib in NRAS- and TERT promoter-mutant radioiodine-refractory differentiated thyroid cancer: a case report.
30 Oct 2026· EJNMMI reports· PUBMED
Publication
AKT1-phosphorylated TERT assembles a FOXO3-MYC transcriptional complex that drives ERphagy and proteostasis in post-mitotic RPE.
26 Oct 2026· Autophagy· PUBMED
Publication
Correction to: "BRAF-induced EHF Expression Affects TERT in Aggressive Papillary Thyroid Cancer".
16 Oct 2026· The Journal of clinical endocrinology and metabolism· PUBMED
Publication
Isolated TERT promoter mutation may define a high-risk prognostic subgroup in papillary thyroid carcinoma: an exploratory, hypothesis-generating analysis of TCGA and GSE33630 datasets.
15 Oct 2026· Frontiers in endocrinology· PUBMED
Publication
CDKN2A deletion associated with poor prognosis in patients with TERT promoter wild-type, IDH wild-type glioblastoma.
10 Oct 2026· Brain tumor pathology· PUBMED
Publication
TERT is a therapeutic target for tertiary stroke prevention.
9 Oct 2026· Journal of advanced research· PUBMED
Publication
TERT reactivation in thyroid cancer: mechanisms, clinical implications, and therapeutic opportunities.
1 Oct 2026· European thyroid journal· PUBMED
Publication
TERT promoter mutations in papillary thyroid carcinoma: association with gross extrathyroidal invasion and outcomes.
1 Oct 2026· European thyroid journal· PUBMED
Publication
TERT Promoter Variants, Older Age, and Prognosis in Papillary Thyroid Carcinoma.
1 Oct 2026· JAMA otolaryngology-- head & neck surgery· PUBMED
Publication
Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations.
30 Sept 2026· Frontiers in oncology· PUBMED
Publication
FOXE1, IMP-3, and TERT expressions in papillary thyroid carcinomas.
28 Sept 2026· Indian journal of pathology & microbiology· PUBMED
Publication
SNP rs2853669 potentially elevates the risk of glioblastoma development and leads to worse prognosis when in cis with mutant TERT promoter in a Japanese cohort.
28 Sept 2026· Neuro-oncology· PUBMED
Publication
LncRNA 34962 drives pulmonary vascular remodeling in pulmonary hypertension due to left heart disease through the miR-3575/cMYC/TERT signaling axis.
24 Sept 2026· European journal of pharmacology· PUBMED
Publication
Multiparametric static hybrid ¹⁸F-FET PET/MR for preoperative prediction of TERT promoter mutation in glioblastoma.
9 Sept 2026· Neuroradiology· PUBMED
Publication
Exploring the Role of TERT Promoter Mutations in Advanced Melanoma Treated With BRAF/MEK Inhibitors or Immune Checkpoint Inhibitors.
1 Sept 2026· Anticancer research· PUBMED
Publication
A rare TERT p.Ala880Thr variant associated with familial pulmonary fibrosis and multisystem involvement: Intrafamilial heterogeneity in a Vietnamese kindred - A case series.
31 Aug 2026· Therapeutic advances in respiratory disease· PUBMED
Publication
USP53-ALKBH5 axis inhibition boosts m6A-modified TERT RNA degradation: A potential therapeutic strategy for glioblastoma.
15 Aug 2026· Biochimica et biophysica acta. Molecular basis of disease· PUBMED
Publication
Clinical and molecular characteristics of thalamic gliomas in adults: prognostic impact of TERT promoter mutation.
14 Aug 2026· Neurosurgical review· PUBMED
Publication
TERT Promoter Mutations Are Preferentially Associated With the ERBB2 G776-Altered Subtype of HER2-Mutant NSCLC.
13 Aug 2026· Cancer science· PUBMED
Publication
Value of TERT promoter mutations for early outcomes in papillary thyroid cancer.
1 Aug 2026· Endocrine-related cancer· PUBMED
Publication
Par-4/TERT induced autophagy dysregulation in regulating glycolysis in hyperglycemia combined with hepatocellular carcinoma.
31 Jul 2026· Journal of bioenergetics and biomembranes· PUBMED
Publication
Correction: Multi-gene co-mutations of BRAF with TERT, PIK3CA, or TP53 are powerful predictors of central lymph node metastasis in papillary thyroid carcinoma.
22 Jul 2026· Frontiers in endocrinology· PUBMED
Publication
BRAF V600E/TERT Promoter Co-Mutation Is Associated with Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Translational Molecular Biomarker Study.
20 Jul 2026· Biomedicines· PUBMED
Publication
Association between autoimmune thyroiditis and BRAFV600E/TERT promoter mutations in patients with papillary thyroid carcinoma from Central Asia, Kazakhstan.
20 Jul 2026· PloS one· PUBMED
Publication
PACT Inhibits Malignant Biological Behavior of Ovarian Cancer Cells by Regulating TERT Expression.
16 Jul 2026· Molecular carcinogenesis· PUBMED
Publication
TERT drives liver tumorigenesis beyond telomere elongation.
2 Jul 2026· Life science alliance· PUBMED
Publication
CRISPRi-Mediated Epigenetic Suppression of TERT Reduces Cell Growth in Non-Small-Cell Lung Cancer Cells.
24 Jun 2026· Cells· PUBMED
Publication
[shRNA-mediated downregulation of TERT inhibits melanoma in vitro and in vivo].
23 Jun 2026· Zhonghua zhong liu za zhi [Chinese journal of oncology]· PUBMED